Ignite Creation Date:
2025-12-24 @ 9:08 PM
Ignite Modification Date:
2026-01-16 @ 5:50 PM
Study NCT ID:
NCT00113204
Status:
COMPLETED
Last Update Posted:
2008-05-20
First Post:
2005-06-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety Study of IPI-504 in Patients With Relapsed and Relapsed Refractory Multiple Myeloma
Sponsor:
Infinity Pharmaceuticals, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Multiple Myeloma | View |